Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy
格罗宁根大学医学中心分子肿瘤委员会 (UMCG-MTB)：接受 MTB 建议的靶向治疗的具有罕见或复杂突变谱的患者的预后
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103966
de Jager, V D; Plomp, P; Paats, M S; van Helvert, S; Elst, A Ter; van den Berg, A; Dubbink, H J; van Geffen, W H; Zhang, L; Hendriks, L E L; Hiltermann, T J N; Hiddinga, B I; Hijmering-Kappelle, L B M; Jalving, M; Kluiver, J; Koopman, B; van Kruchten, M; van der Logt, E M J; Piet, B; van Putten, J; Reitsma, B H; Rutgers, S R; de Vries, M; Stigt, J A; Groves, M R; Timens, W; Willems, S M; van Kempen, L C; Schuuring, E; van der Wekken, A J
